艾勒朗制药 (ALRN.O)

+ 收藏

财务摘要(报告期)(艾勒朗制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
每股指标:
 每股收益EPS基本(元) 会员可见会员可见会员可见会员可见-1.45-1.05
 每股净资产(元) 会员可见会员可见会员可见会员可见2.823.14
 每股经营现金净流量(元) 会员可见会员可见会员可见会员可见-1.71-1.03
 每股现金流量净额(元) 会员可见会员可见会员可见会员可见1.760.57
盈利能力:
 净资产收益率平均(%) 会员可见会员可见会员可见会员可见-41.80-29.06
 总资产净利率(%) 会员可见会员可见会员可见会员可见-36.48-24.41
 投入资本回报率ROIC(%) 会员可见会员可见会员可见会员可见-74.46-36.50
收益质量:
 营业利润/利润总额(%) 会员可见会员可见会员可见会员可见106.66104.85
资本结构:
 资产负债率(%) 会员可见会员可见会员可见会员可见8.5616.81
 权益乘数 会员可见会员可见会员可见会员可见1.091.20
 产权比率 会员可见会员可见会员可见会员可见0.090.20
 流动资产/总资产(%) 会员可见会员可见会员可见会员可见99.7299.70
 非流动资产/总资产(%) 会员可见会员可见会员可见会员可见0.280.30
 流动负债/负债合计(%) 会员可见会员可见会员可见会员可见100.00100.00
 非流动负债/负债合计(%) 会员可见会员可见会员可见---
 归属母公司股东的权益/投入资本(%) 会员可见会员可见会员可见会员可见1,552.67152.26
偿债能力:
 流动比率 会员可见会员可见会员可见会员可见11.665.93
 速动比率 会员可见会员可见会员可见会员可见11.665.93
 货币资金/流动负债(%) 会员可见会员可见会员可见会员可见1,100.00269.87
 营业利润/流动负债(%) 会员可见会员可见会员可见会员可见-585.05-173.75
 经营活动产生的现金流量净额/流动负债(%) 会员可见会员可见会员可见会员可见-649.71-161.62
 归属母公司股东的权益/负债合计(%) 会员可见会员可见会员可见会员可见1,068.84494.90
 经营活动产生的现金流量净额/负债合计(%) 会员可见会员可见会员可见会员可见-649.71-161.62
 营业利润/负债合计(%) 会员可见会员可见会员可见会员可见-585.05-173.75
成长能力:
 总资产同比增长率(%) 会员可见会员可见会员可见会员可见-58.57-57.38
 每股净资产同比增长率(%) 会员可见会员可见会员可见会员可见794.09690.55
 总负债同比增长率(%) 会员可见会员可见会员可见会员可见-76.76-30.44
 基本每股收益同比增长率(%) 会员可见会员可见会员可见会员可见59.9443.55
 归属母公司股东的权益同比增长率(%) 会员可见会员可见会员可见会员可见-55.30-60.47
 营业利润同比增长率(%) 会员可见会员可见会员可见会员可见57.4640.49
 股东权益合计同比增长率(%) 会员可见会员可见会员可见会员可见-55.30-60.47
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) 会员可见会员可见会员可见会员可见5,539,000.00334,000.00
 利润总额TTM(元) 会员可见会员可见会员可见会员可见-17,481,000.00-23,686,000.00
 投入资本(元) 会员可见会员可见会员可见会员可见824,000.009,374,000.00
 经营活动产生的现金流量净额TTM(元) 会员可见会员可见会员可见会员可见-19,157,000.00-21,726,000.00
 归属母公司净利润TTM(元) 会员可见会员可见会员可见会员可见-17,481,000.00-23,686,000.00

前瞻产业研究院